[#item_full_content]
Eli Lilly’s Early Alzheimer’s Treatment Donanemab Scores Japanese Approval, Its Second Largest Market
2024-09-24T13:23:52-04:00September 24th, 2024|
Related Posts
-
Here’s what China’s biggest stimulus since Covid means for our 32 stock portfolio
September 24th, 2024 -
Here’s what China’s biggest stimulus since Covid means for our 32 stock portfolio
September 24th, 2024 -
Moving Markets: GDP, PCE, And More This Week (SP500)
September 24th, 2024 -
Starbucks CEO hype has been ‘overdone,’ Jefferies analysts say in rare downgrade
September 24th, 2024